PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application and Genetic Testing
The goal of this activity is to improve participants' knowledge of, confidence in, and competence in integrating PARP inhibitors into treatment of patients with breast cancer.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Hepatobiliary Cancers, Version 2.2019
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts.
Category
  • Hepatocellular Carcinoma
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - B-Cell Lymphomas, Version 3.2019
These NCCN Guidelines Insights highlight important updates to the NCCN Guidelines for B-Cell Lymphomas regarding the treatment of TFL and relapsed/refractory FL and DLBCL.
Category
  • Non-Hodgkin's Lymphoma
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - B-Cell Lymphomas
During this tumor board, the faculty will discuss recent advances in the diagnosis and treatment of diffuse large B-cell lymphomas (DLBCL).
Category
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Best Practices in Immunotherapy Symptom Management and Patient Education
The NCCN Guidelines provide recommendations for managing irAEs as well as guiding principles for immunosuppression in the setting of toxicity. Importantly, these guidelines also provide guidance for multidisciplinary teams regarding clinician and patient education.
Category
  • Palliative Care
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Management of Toxicities Associated with Immune Checkpoint Inhibitors
It is important for hematology/oncology nurses to gain knowledge about current management strategies and new treatment guidelines to support timely detection and management of potentially life-threatening adverse events.
Category
  • Hematologic Malignancies
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Recognition and Management of Immunotherapy-Related Toxicity
Current management strategies are primarily based on clinical experience from high-volume centers, and many clinicians have limited experience managing immunotherapy-related toxicity. Education and training are needed to manage the needs of the growing patient population treated with these agents.
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Recorded Presentation from the NCCN 2018-2019 Oncology Case Manager and Medical Director Program: Recent Developments in Cancer Immunotherapy
The field of cancer immunotherapy has evolved dramatically in recent years. As increasingly greater options for, and combinations of, cancer immunotherapy become available, clinicians need to stay up-to-date on the role of immunotherapy in a rapidly changing therapeutic landscape.
Category
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Keynote Session: Patient Experience with Innovative Therapies
The development of new and innovative cancer treatments has expanded the options available to manage patients with cancer.  However, with these advances come challenges for healthcare providers and patients.
Category
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
  • Palliative Care
  • Supportive Care Topics
  • Survivorship
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
CAR T-Cell Therapy: Recent Advances and Future Considerations
NCCN organized a task force consisting of a multidisciplinary panel of experts in oncology, cancer center administration, and health policy, which met for the first time in March 2018. This webinar describes the current state of CAR T-cell therapy and future strategies that should be considered as the application of this novel immunotherapy expands and evolves.
Category
  • Acute Lymphoblastic Leukemia
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages